<DOC>
	<DOCNO>NCT00200551</DOCNO>
	<brief_summary>The trial plan multicentric , randomize , prospective , open study accordance 1/1 plan , parallel group 2 arm treatment . A total 200 patient chronic renal insufficiency , include French national wait list Establishment Français des Greffes [ French Transplants Institution ] receive first renal transplant include , sign agreement , study . All patient receive organ take brain-dead subject . The patient give immunosuppressant treatment base rabbit anti-T lymphocyte serum , CellCeptÒ NeoralÒ cyclosporin . One group 100 randomise patient give standard corticosteroid therapy well first six month follow transplant . This group compare second group 100 randomise patient give single dose corticosteroid . The main aim study evaluate number acute rejection episode patient give first renal transplant subject immunosuppressant protocol contain corticosteroid . The hypothesis propose , absence corticosteroid and/or calcineurin inhibitor ( i.e . cyclosporin tacrolimus ) , antilymphocyte serum result certain state `` tolerance '' respect allograft . The second objective concern beneficial effect absence corticosteroid may short- long-term postoperative morbidity mortality . One may fact assume absence corticosteroid result extension transplant patient 's life expectancy result reduction cardiovascular complication . Cardiovascular complication frequent cause death renal transplant .</brief_summary>
	<brief_title>A Study Mycophenolate Mofetil Cyclosporin , Without Concomitant Corticosteroids , After First Renal Transplant</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<criteria>Patient candidate first cadaver renal transplantation include national list Etablissement Français des Greffes Man woman age 18 65 year Women reproductive age must agree use reliable contraceptive method throughout first year study Donor age 18 65 year Patient give full information study give write informed consent take part . Women pregnant breastfeeding Patient immunological risk consider high define percentage antiHLA antibodies ³20 % ( previous recent determination T lymphocytes ) Patient history allergy rabbit protein Cold ischaemia time 36 hour Patient allergic macrolide antibiotic , tacrolimus MMF Patient immunosuppressant treatment transplantation Patient suffer malignant neoplasm history malignant neoplasia , exception treat baso spinocellular cancer Patient wait another transplant addition kidney Patient already receive organ tissue graft Leukocyte count &lt; 2000/mm3 and/or platelet count &lt; 50 000/mm3 Patient suffer focal glomerulonephritis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>